Indi(R) Announces Availability of Xpresys(TM) Lung Blood Test With Potential to Help Physicians Identify More Lung Nodules as Likely Benign and More Patients as Possible Candidates for Active Surveillance Instead of Invasive Procedures
October 28, 2013 06:00 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Oct 28, 2013) - Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the availability of Xpresys Lung, a protein expression blood...
Study Suggests Indi Blood Test Can Differentiate Between Benign Lung Nodules and Early Stage Lung Cancer
October 16, 2013 14:00 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwired - Oct 16, 2013) - Indi (Integrated Diagnostics), an emerging leader in molecular diagnostics, today announced the results of a major study which suggests that quantifying...
Indi Molecular Launches With $1.5 Million Seed Round Led by Interwest Partners
September 20, 2013 07:30 ET
|
Integrated Diagnostics
SEATTLE, WA and CULVER CITY, CA--(Marketwired - Sep 20, 2013) - Indi Molecular, which pioneered a synthetic replacement for antibodies, today announced that it has raised a $1.5 million seed round...
Integrated Diagnostics(R) Appoints CFO & VP Sales Prior to Launch of Lung Cancer Diagnostic
March 06, 2013 08:02 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Mar 6, 2013) - Integrated Diagnostics (Indi®), an emerging leader in molecular diagnostics, today announced that it has appointed John Bencich as chief financial...
Integrated Diagnostics(R) Launches Imaging Division to Create PET Imaging Probes
June 13, 2012 08:01 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Jun 13, 2012) - Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has launched a new operating division,...
Integrated Diagnostics(R) Secures $10 Million Third Tranche of Series A Financing
February 22, 2012 07:01 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Feb 22, 2012) - Integrated Diagnostics (InDi®), an emerging leader in molecular diagnostics, today announced that the company has made substantial progress in its...
Caltech and Integrated Diagnostics Researchers Receive Grand Challenges Point-of-Care Diagnostics Grant
December 16, 2011 13:04 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Dec 16, 2011) - Integrated Diagnostics announced today that researchers from the company and the California Institute of Technology (Caltech) will receive a Point-of-Care...
Integrated Diagnostics Licenses "Click Chemistry" From The Scripps Research Institute, Strengthening Partner Network
October 26, 2011 06:03 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Oct 26, 2011) - Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has signed a worldwide licensing agreement with The Scripps...
Integrated Diagnostics and Caltech Researchers Jointly Create Synthetic Class of Diagnostic and Therapeutic Agents With Antibody-Like Properties
October 26, 2011 06:03 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - Oct 26, 2011) - Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has created a synthetic class of diagnostic and therapeutic...
Integrated Diagnostics Appoints Jay Moyes to Board of Directors
March 09, 2011 06:03 ET
|
Integrated Diagnostics
SEATTLE, WA--(Marketwire - March 9, 2011) - Integrated Diagnostics, an emerging leader in molecular diagnostics founded by Lee Hood, M.D., Ph.D., today announced that Jay Moyes has joined the...